Kiyan Heybati

ORCID: 0000-0003-4465-2249
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Intensive Care Unit Cognitive Disorders
  • Cardiac Arrhythmias and Treatments
  • Atrial Fibrillation Management and Outcomes
  • Cardiac, Anesthesia and Surgical Outcomes
  • COVID-19 Clinical Research Studies
  • Sepsis Diagnosis and Treatment
  • Respiratory Support and Mechanisms
  • Anesthesia and Sedative Agents
  • Cardiac pacing and defibrillation studies
  • Pharmacological Receptor Mechanisms and Effects
  • Parasitic Diseases Research and Treatment
  • Adrenal Hormones and Disorders
  • Cardiac Health and Mental Health
  • Diversity and Career in Medicine
  • Healthcare cost, quality, practices
  • Palliative Care and End-of-Life Issues
  • Vitamin C and Antioxidants Research
  • Artificial Intelligence in Healthcare and Education
  • SARS-CoV-2 and COVID-19 Research
  • Cardiovascular Syncope and Autonomic Disorders
  • Anesthesia and Pain Management
  • Long-Term Effects of COVID-19
  • Hip and Femur Fractures
  • Meta-analysis and systematic reviews
  • Anesthesia and Neurotoxicity Research

WinnMed
2021-2025

Mayo Clinic in Arizona
2021-2025

Mayo Clinic
2021-2025

Jacksonville College
2023-2024

Mayo Clinic in Florida
2023-2024

New York Academy of Sciences
2023

John Wiley & Sons (Germany)
2023

Moss Landing Marine Laboratories
2023

Hudson Institute
2023

Mayo Clinic Hospital
2023

Introduction Propofol is a widely used sedative-hypnotic agent for critically ill patients requiring invasive mechanical ventilation (IMV). Despite its clinical benefits, propofol associated with increased risks of hypertriglyceridemia. Early identification at risk propofol-associated hypertriglyceridemia crucial optimising sedation strategies and preventing adverse outcomes. Machine-learning (ML) models offer promising approach predicting individualised patient Methods analysis We propose...

10.1136/bmjopen-2024-092594 article EN cc-by-nc-nd BMJ Open 2025-01-01

Anesthesiologists are often tasked with overseeing sedation in non-surgical settings. We aim to determine whether adding adjuvant sedatives propofol affects the recovery times and complication rates after endoscopy. conducted a retrospective cohort study of adults (≥18) who received while undergoing Esophagogastroduodenoscopy (EGD) and/or Colonoscopy (COL) at large academic institution over four-year period. Patients receiving alone were compared against patients combination midazolam,...

10.1016/j.bjane.2025.844602 article EN cc-by Brazilian Journal of Anesthesiology (English Edition) 2025-02-01
Coming Soon ...